Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Peball

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|May 29, 2026
Long-Term Use of Tiapride and Tetrabenazine in Huntington's Disease: A 25-Year Retrospective Single-Center AnalysisKatarína Schwarzová, Samuel Labrecque, Greta Hemicker, et al.
Brain Sciences|May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot StudyPhilipp Ellmerer, Marina Peball, Federico Carbone, et al.
Journal of Neurology|February 1, 2025
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's diseaseBeatrice Heim, Elias Mandler, Marina Peball, et al.
Orphanet Journal of Rare Diseases|January 10, 2026
Bridging the gap: sex-specific differences in Huntington's diseaseGreta Hemicker, Katarína Schwarzová, Samuel Labrecque, et al.
NPJ Parkinson'S Disease|March 16, 2024
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s DiseaseMarina Peball, Beatrice Heim, Federico Carbone, et al.
Frontiers in Neuroscience|June 11, 2025
Neck and mind: exploring emotion processing in cervical dystoniaFederico Carbone, Marina Peball, Philipp Ellmerer, et al.
Movement Disorders Clinical Practice|March 27, 2024
Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's DiseaseBeatrice Heim, Elias Mandler, Arabella Buchmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2025
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's DiseaseGreta Hemicker, Clancy Cerejo, Marina Peball, et al.
BMJ Open|May 28, 2025
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in InnsbruckNicolas De Cleene, Frank Jagusch, Joachim Schmutzhard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 17, 2024
Sex-related differences in the clinical presentation of multiple system atrophyFabian Leys, Sabine Eschlböck, Nicole Campese, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|May 29, 2026
Long-Term Use of Tiapride and Tetrabenazine in Huntington's Disease: A 25-Year Retrospective Single-Center AnalysisKatarína Schwarzová, Samuel Labrecque, Greta Hemicker, et al.
Brain Sciences|May 28, 2022
Eye Tracking in Patients with Parkinson's Disease Treated with Nabilone-Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot StudyPhilipp Ellmerer, Marina Peball, Federico Carbone, et al.
Journal of Neurology|February 1, 2025
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington's diseaseBeatrice Heim, Elias Mandler, Marina Peball, et al.
Orphanet Journal of Rare Diseases|January 10, 2026
Bridging the gap: sex-specific differences in Huntington's diseaseGreta Hemicker, Katarína Schwarzová, Samuel Labrecque, et al.
NPJ Parkinson'S Disease|March 16, 2024
Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s DiseaseMarina Peball, Beatrice Heim, Federico Carbone, et al.
Frontiers in Neuroscience|June 11, 2025
Neck and mind: exploring emotion processing in cervical dystoniaFederico Carbone, Marina Peball, Philipp Ellmerer, et al.
Movement Disorders Clinical Practice|March 27, 2024
Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's DiseaseBeatrice Heim, Elias Mandler, Arabella Buchmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2025
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's DiseaseGreta Hemicker, Clancy Cerejo, Marina Peball, et al.
BMJ Open|May 28, 2025
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in InnsbruckNicolas De Cleene, Frank Jagusch, Joachim Schmutzhard, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|April 17, 2024
Sex-related differences in the clinical presentation of multiple system atrophyFabian Leys, Sabine Eschlböck, Nicole Campese, et al.
Pageof 5